When a widely accepted theory couldn’t explain the data, Dalhaimer’s lab looked deeper—and revealed new possibilities for nanoparticle medicine.

UT CBE alumnus Monireh Asoudeh (’22) shares her college experience, as well as her job as a research scientist at Stanford University’s School of Medicine.

SR-BI, the receptor for high-density lipoprotein (HDL; “good cholesterol”) is one of the most sought after targets for treating metabolic […]

Eukaryotic cells store cholesterol/sterol esters (SEs) and triacylglycerols (TAGs) in lipid droplets, which form from the contiguous endoplasmic reticulum (ER) […]

Associate Professor Paul Dalhaimer is researching the molecular mechanisms governing the onsets of obesity and type 2 diabetes.